Usage
Benzalkonium Chloride + Gatifloxacin ophthalmic solution is prescribed for the treatment of bacterial conjunctivitis (pink eye) in adults and children 1 year of age and older. It is also used for other superficial ocular infections like bacterial keratitis and corneal ulcers.
Pharmacological classification:
- Benzalkonium chloride: Antiseptic, preservative
- Gatifloxacin: Fluoroquinolone antibiotic
Mechanism of Action:
Benzalkonium chloride acts as a preservative and antiseptic by disrupting bacterial cell membranes. Gatifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and repair, leading to bacterial cell death.
Alternate Names
Gatifloxacin ophthalmic solution often includes benzalkonium chloride as a preservative, hence a specific combination name isn’t commonly used. However, gatifloxacin itself may be referred to as its chemical name or by various brand names.
Brand Names:
Several brand names exist depending on the region and manufacturer, these include Zymar®, Zymaxid®, Gatistar®, QUINOGET, and various generic formulations like Apo-Gatifloxacin and Sandoz Gatifloxacin.
How It Works
Pharmacodynamics:
Benzalkonium chloride disrupts bacterial cell membranes, leading to cell death. Gatifloxacin inhibits bacterial DNA replication and repair, thereby preventing bacterial growth and leading to bacterial cell death.
Pharmacokinetics:
- Absorption: When applied topically to the eye, minimal systemic absorption of gatifloxacin occurs. Serum gatifloxacin levels are typically undetectable after topical ocular administration.
- Metabolism: Limited information is available on the specific metabolic pathways of topical gatifloxacin. However, systemic gatifloxacin is primarily metabolized by the liver.
- Elimination: Systemic gatifloxacin is predominantly eliminated by the kidneys. Elimination pathways for topical gatifloxacin have not been fully elucidated.
Mode of Action:
Benzalkonium chloride disrupts bacterial cell wall integrity. Gatifloxacin inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. This inhibition blocks bacterial DNA replication and transcription, leading to bacterial cell death.
Receptor binding, enzyme inhibition, or neurotransmitter modulation:
Gatifloxacin inhibits DNA gyrase and topoisomerase IV. Benzalkonium chloride does not have specific receptor binding, enzyme inhibition, or neurotransmitter modulation effects related to its ophthalmic use. Its action is primarily related to its surfactant properties.
Elimination pathways:
The elimination pathways after topical ophthalmic administration are not well-defined. For systemic gatifloxacin, the primary route of elimination is renal, with some hepatic metabolism.
Dosage
Standard Dosage
Adults and Children (1 year and older):
- Days 1-2: Instill one drop in the affected eye(s) every two hours while awake, up to 8 times per day.
- Days 3-7: Instill one drop in the affected eye(s) 2 to 4 times daily while awake.
Children (under 1 year):
Safety and efficacy have not been established in children younger than 1 year of age.
Special Cases:
- Elderly Patients: No dosage adjustment is typically required. However, closer monitoring is recommended.
- Patients with Renal Impairment: Dose adjustment isn’t typically necessary for topical ophthalmic administration due to minimal systemic absorption.
- Patients with Hepatic Dysfunction: Dosage adjustments aren’t usually needed with topical use.
- Patients with Comorbid Conditions: Exercise caution and monitor closely.
Clinical Use Cases
Dosing for specific medical settings generally aligns with the standard dosage recommendations. Prophylactic use before intraocular surgery often involves instilling one drop 4 times a day for 3 days before the procedure.
Dosage Adjustments:
Dosage adjustments based on renal/hepatic dysfunction, metabolic disorders, or genetic polymorphisms are usually not necessary for topical application due to minimal systemic absorption.
Side Effects
Common Side Effects:
- Eye irritation
- Blurred vision
- Unpleasant taste in the mouth (dysgeusia)
- Eye dryness, tearing, discharge
- Eye pain
- Headache
- Runny nose
- Sneezing
- Sore throat
Rare but Serious Side Effects:
- Hypersensitivity reactions (anaphylaxis, angioedema, dyspnea, urticaria, itching)
- Stevens-Johnson syndrome
- Tendon inflammation and/or rupture
Long-Term Effects:
- Corneal endothelial cell injury with prolonged use
- Development of resistant organisms with prolonged use
Adverse Drug Reactions (ADR):
Serious hypersensitivity reactions and signs of tendon inflammation or rupture require immediate medical intervention. Corneal changes warrant ophthalmological assessment.
Contraindications
- Hypersensitivity to gatifloxacin, other quinolones, or any component of the formulation (e.g., benzalkonium chloride).
- Epithelial herpes simplex keratitis (dendritic keratitis)
- Viral or fungal ocular infections
Drug Interactions
Limited formal drug interaction studies have been conducted with gatifloxacin ophthalmic solution. However, potential interactions include:
- Other ophthalmic drops, particularly those containing silver
- Systemic quinolones (may increase risk of systemic side effects)
- Corticosteroids (concurrent use may increase the risk of tendon rupture)
Pregnancy and Breastfeeding
-
Pregnancy: Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Topical gatifloxacin has not been adequately studied in pregnant women. Animal studies have shown teratogenic effects at high systemic doses.
-
Breastfeeding: Gatifloxacin is excreted in rat milk. It is unknown if it is excreted in human milk. Caution is advised when administering to nursing mothers. Consider the potential benefits of breastfeeding and the importance of the drug to the mother, alongside potential adverse effects on the breastfed infant.
Drug Profile Summary
- Mechanism of Action: Inhibits bacterial DNA gyrase and topoisomerase IV. Benzalkonium chloride acts as a preservative and antiseptic.
- Side Effects: Eye irritation, blurred vision, dysgeusia, eye dryness, eye pain, headache. Rarely, hypersensitivity, tendon rupture.
- Contraindications: Hypersensitivity to fluoroquinolones or any component of the formulation, herpes simplex keratitis, viral/fungal ocular infections.
- Drug Interactions: Limited formal studies. Monitor concurrent use with other ophthalmic medications, systemic quinolones, corticosteroids.
- Pregnancy & Breastfeeding: Use with caution. Weigh potential benefits against risks.
- Dosage: Adults and children ≥1 year: Days 1-2: 1 drop every 2 hours (up to 8 times/day); Days 3-7: 1 drop 2-4 times/day.
- Monitoring Parameters: Monitor for ocular irritation, vision changes, signs of hypersensitivity, and tendon pain or inflammation.
Popular Combinations
Gatifloxacin is sometimes combined with corticosteroids like prednisolone for enhanced anti-inflammatory effects.
Precautions
- General Precautions: Avoid contact of bottle tip with eye. Patients should not wear contact lenses during treatment.
- Specific Populations: Consult with healthcare professional for pregnant women, lactating mothers, and children under one year of age.
- Menstruating Individuals: Not applicable.
FAQs (Frequently Asked Questions)
Q1: What is the recommended dosage for Benzalkonium Chloride + Gatifloxacin?
A: For adults and children 1 year and older, instill one drop every 2 hours while awake (up to 8 times/day) for the first two days. From day 3 to 7, instill one drop 2-4 times/day while awake.
A: No, you should not wear contact lenses while using this medication.
Q3: What should I do if I miss a dose?
A: Instill the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not instill a double dose to catch up.
Q4: What are the most common side effects of this medication?
A: The most common side effects include eye irritation, blurred vision, and an unusual taste in the mouth.
Q5: How long does treatment with this medication usually last?
A: Treatment typically lasts for 7 days.
Q6: Is this medication safe to use during pregnancy?
A: There are limited studies on the use of this medication during pregnancy. It should only be used if the potential benefit outweighs the potential risk to the fetus. Consult with your doctor before using this medication if you are pregnant.
Q7: Can I use this medication if I am breastfeeding?
A: It is unknown if gatifloxacin is excreted in human milk. Exercise caution and consult your doctor to assess the risks and benefits.
Q8: What should I do if I experience severe side effects?
A: Immediately discontinue use and seek medical attention.
Q9: Can this medication be used for other eye infections besides bacterial conjunctivitis?
A: While primarily used for bacterial conjunctivitis, it can also be used for other superficial ocular infections like bacterial keratitis and corneal ulcers under the guidance of a healthcare professional.
Q10: What is the role of benzalkonium chloride in this medication?
A: Benzalkonium chloride acts as a preservative to prevent bacterial contamination of the eye drops and also exhibits some antiseptic activity.
